Article

Low antioxidant levels and exposure to sunlight likely to damage vision

The combination of low antioxidant levels and exposure to sunlight may damage vision and also is linked to age-related macular degeneration, according to a study published in the October issue of the Archives of Ophthalmology.

London-The combination of low antioxidant levels and exposure to sunlight may damage vision and also is linked to age-related macular degeneration (AMD), according to a study published in the October issue of the Archives of Ophthalmology.

Studies suggest that blue light or short-wavelength light may damage the retina and contribute to the development of AMD. Antioxidant enzymes including vitamins C and E, the carotenoids, lutein, zeaxanthin, and zinc may protect against the harmful effects of blue light on the retina, according to a prepared statement from the American Medical Association.

“The retina is vulnerable to the damaging effects of light,” wrote study authors. “While wavelengths in the UV radiation range are largely absorbed by the cornea and lens, the retina is exposed to visible light, including blue light.”

Of the 4,400 participants of the European Eye Study, 2,117 did not have AMD, 101 had neovascular AMD, and 2,182 had early stage AMD. Although there was no association between blue-light exposure and early AMD, blue-light exposure was associated with neovascular AMD in one-fourth of individuals with the lowest antioxidant levels.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.